{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:23:39Z","timestamp":1758050619418,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bulcan.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T05:52:42Z","timestamp":1604555562000},"page":"1260-1273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quoi de neuf dans la prise en charge des tumeurs fibreuses solitaires\/h\u00e9mangiop\u00e9ricytomes des m\u00e9ninges\u00a0?"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3126-3351","authenticated-orcid":false,"given":"Marine","family":"Lottin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Escande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Peyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henri","family":"Sevestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude Alain","family":"Maurage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Chauffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Penel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2020.09.011_bib0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1017\/cjn.2019.311","article-title":"Nervous system hemangiopericytoma","volume":"47","author":"Cohen-Inbar","year":"2020","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"10.1016\/j.bulcan.2020.09.011_bib0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bpa.12613","article-title":"Grading of meningeal solitary fibrous tumors\/hemangiopericytomas: analysis of the prognostic value of the Marseille Grading System in a cohort of 132\u00a0patients","volume":"29","author":"Macagno","year":"2019","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.011_bib0205","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1227\/00006123-198910000-00003","article-title":"Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44\u00a0cases","volume":"25","author":"Guthrie","year":"1989","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.011_bib0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3340\/jkns.2013.54.4.309","article-title":"Clinical analysis of intracranial hemangiopericytoma","volume":"54","author":"Park","year":"2013","journal-title":"J Korean Neurosurg Soc"},{"issue":"3\u20134","key":"10.1016\/j.bulcan.2020.09.011_bib0215","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.wneu.2013.11.009","article-title":"Intracranial hemangiopericytoma \u2013 our experience in 30\u00a0years: a series of 43\u00a0cases and review of the literature","volume":"81","author":"Melone","year":"2014","journal-title":"World Neurosurg"},{"issue":"7","key":"10.1016\/j.bulcan.2020.09.011_bib0220","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/cncr.20109","article-title":"Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29\u00a0cases and review of the literature","volume":"100","author":"Soyuer","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2020.09.011_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/690251","article-title":"Solitary fibrous tumors and so-called hemangiopericytoma","volume":"2012","author":"Penel","year":"2012","journal-title":"Sarcoma"},{"issue":"2","key":"10.1016\/j.bulcan.2020.09.011_bib0230","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejrad.2010.02.016","article-title":"Intracranial solitary fibrous tumor: imaging findings","volume":"80","author":"Claren\u00e7on","year":"2011","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.011_bib0235","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1158\/1078-0432.CCR-10-2621","article-title":"Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors","volume":"17","author":"Quek","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bulcan.2020.09.011_bib0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jocn.2016.10.002","article-title":"Gamma knife radiosurgery for residual or recurrent intracranial hemangiopericytomas","volume":"35","author":"Kim","year":"2017","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.bulcan.2020.09.011_bib0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-3019(02)00917-5","article-title":"Meningeal hemangiopericytomas","volume":"59","author":"Kim","year":"2003","journal-title":"Surg Neurol"},{"issue":"17","key":"10.1016\/j.bulcan.2020.09.011_bib0250","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1016\/j.ejca.2014.09.004","article-title":"Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour","volume":"50","author":"Stacchiotti","year":"2014","journal-title":"Eur J Cancer"},{"issue":"21","key":"10.1016\/j.bulcan.2020.09.011_bib0255","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1002\/cncr.26098","article-title":"Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor","volume":"117","author":"Park","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2020.09.011_bib0260","first-page":"354","article-title":"The radiation therapy options of intracranial hemangiopericytoma: an overview and update on a rare vascular mesenchymal tumor","volume":"12","author":"Ciliberti","year":"2018","journal-title":"Oncol Rev"},{"key":"10.1016\/j.bulcan.2020.09.011_bib0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1746-160X-8-3","article-title":"Usefulness of choline-PET for the detection of residual hemangiopericytoma in the skull base: comparison with FDG-PET","volume":"8","author":"Ito","year":"2012","journal-title":"Head Face Med"},{"issue":"6","key":"10.1016\/j.bulcan.2020.09.011_bib0270","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3171\/2017.1.JNS162593","article-title":"Intracranial solitary fibrous tumors\/hemangiopericytomas: first report of malignant progression","volume":"128","author":"Apra","year":"2018","journal-title":"J Neurosurg"},{"issue":"11","key":"10.1016\/j.bulcan.2020.09.011_bib0275","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.prp.2017.08.011","article-title":"Molecular characterization of a series of solitary fibrous tumors, including immunohistochemical expression of STAT6\u00a0and NATB2-STAT6\u00a0fusion transcripts, using Reverse Transcriptase(RT)-Polymerase chain reaction(PCR) technique: an Indian experience","volume":"213","author":"Rekhi","year":"2017","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.011_bib0280","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00401-019-01968-3","article-title":"Prognostic significance of NAB2\u2013STAT6\u00a0fusion variants and TERT promotor mutations in solitary fibrous tumors\/hemangiopericytomas of the CNS: not (yet) clear","volume":"137","author":"Vogels","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.09.011_bib0285","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.2509","article-title":"Identification of recurrent NAB2-STAT6\u00a0gene fusions in solitary fibrous tumor by integrative sequencing","volume":"45","author":"Robinson","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.bulcan.2020.09.011_bib0290","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1470-2045(19)30826-5","article-title":"Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2\u00a0trial","volume":"21","author":"Martin-Broto","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.09.011_bib0295","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/path.2715","article-title":"IGF2\u00a0over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting","volume":"221","author":"Hajdu","year":"2010","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2020.09.011_bib0300","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1186\/s12885-015-1697-8","article-title":"Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group","volume":"15","author":"Khalifa","year":"2015","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2020.09.011_bib0305","doi-asserted-by":"crossref","first-page":"64497","DOI":"10.1371\/journal.pone.0064497","article-title":"Gene expression profiling of solitary fibrous tumors","volume":"8","author":"Bertucci","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bulcan.2020.09.011_bib0310","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ijrobp.2012.05.042","article-title":"The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database","volume":"85","author":"Stessin","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.011_bib0315","first-page":"75","article-title":"Meningeal hemangiopericytoma: a retrospective study of 21\u00a0patients with special review of postoperative external radiotherapy","volume":"48","author":"Dufour","year":"2001","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.bulcan.2020.09.011_bib0320","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jso.2930220306","article-title":"Treatment of advanced malignant hemangiopericytoma with combination adriamycin and dtic: a report of four cases","volume":"22","author":"Beadle","year":"1983","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.011_bib0325","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1227\/01.NEU.0000325494.69836.51","article-title":"Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma","volume":"63","author":"Chamberlain","year":"2008","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.bulcan.2020.09.011_bib0330","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1470-2045(18)30676-4","article-title":"Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2\u00a0trial","volume":"20","author":"Martin-Broto","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.09.011_bib0335","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11060-018-2870-0","article-title":"Pazopanib efficacy in recurrent central nervous system hemangiopericytomas","volume":"139","author":"Apra","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.bulcan.2020.09.011_bib0340","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejca.2018.10.024","article-title":"Activity of axitinib in progressive advanced solitary fibrous tumour: results from an exploratory, investigator-driven phase 2\u00a0clinical study","volume":"106","author":"Stacchiotti","year":"2019","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2020.09.011_bib0345","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3171\/2010.3.JNS091882","article-title":"Predictors of mortality following treatment of intracranial hemangiopericytoma","volume":"113","author":"Rutkowski","year":"2010","journal-title":"JNS"},{"issue":"11","key":"10.1016\/j.bulcan.2020.09.011_bib0350","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/cncr.21448","article-title":"Precision radiotherapy for hemangiopericytomas of the central nervous system","volume":"104","author":"Combs","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.011_bib0355","first-page":"905","article-title":"Radiosurgery for treatment of recurrent intracranial hemangiopericytomas","volume":"51","author":"Sheehan","year":"2002","journal-title":"Neurosurgery"},{"issue":"6","key":"10.1016\/j.bulcan.2020.09.011_bib0360","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3171\/jns.2003.98.6.1182","article-title":"Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38\u00a0patients","volume":"98","author":"Ecker","year":"2003","journal-title":"J Neurosurg"},{"issue":"5","key":"10.1016\/j.bulcan.2020.09.011_bib0365","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2008.03.024","article-title":"Adjuvant stereotactic radiosurgery after resection of intracranial hemangiopericytomas","volume":"72","author":"Kano","year":"2008","journal-title":"Int J Radiat Oncol Biol Physics"},{"issue":"1","key":"10.1016\/j.bulcan.2020.09.011_bib0370","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-3329-3-7","article-title":"The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis","volume":"3","author":"Park","year":"2013","journal-title":"Clin Sarcoma Res"},{"issue":"6","key":"10.1016\/j.bulcan.2020.09.011_bib0375","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1177\/1078155218784760","article-title":"Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: a population-based analysis","volume":"25","author":"De Lemos","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10.1016\/j.bulcan.2020.09.011_bib0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jamaoncol.2017.1617","article-title":"Use of PD-1\u00a0targeting, macrophage infiltration, and IDO pathway activation in sarcomas: a phase 2\u00a0clinical trial","volume":"4","author":"Toulmonde","year":"2018","journal-title":"JAMA Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120304094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120304094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:33:22Z","timestamp":1757792002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455120304094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0007455120304094"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.09.011","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quoi de neuf dans la prise en charge des tumeurs fibreuses solitaires\/h\u00e9mangiop\u00e9ricytomes des m\u00e9ninges\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}